Events
SABCS 2025: Adding tucatinib to first-line maintenance therapy delayed disease progression in HER2-positive metastatic breast cancer in HER2CLIMB-05 trial
- SABCS 2025: A multimodal AI model may improve recurrence risk stratification in early breast cancer
- SABCS 2025: Sacituzumab govitecan-hziy led to similar progression-free survival as standard of care for certain endocrine therapy-refractory advanced breast cancers
- SABCS 2025: Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations
AGITG 2023 Wrap-Up with Katie Garman and Ben Lawrence
How can we change our inner worlds alongside our healthcare systems? How can we integrate trust and kindness into research…
‘I’m not going to be cured’. How breast cancer awareness and support sidelines people with metastatic disease
Sophie Lewis, University of Sydney; Andrea Smith, University of Sydney, and Katherine Kenny, University of Sydney There have been incredible…










